Codeine Phosphate

磷酸可待因

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCodeine Phosphate
Drug Alias Name可待因磷酸盐镇咳剂三磷酸可待因锭ActacodeCodeisan +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsDiarrheaAcute PainPain +[5] 
Global Approved IndicationsDiarrheaAcute PainPain +[5] 
Approved Indications in ChinaPainCoughAnesthesia
Original Approved Country/TerritoryJapan
Original Approved Date1913/01/01
Country/TerritoryCanadaUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Uk LtdYichang Humanwell Pharmaceutical Co LtdTakeda Pharmaceutical Company Limited, Hikari Plant
Inactive CompaniesN/A
Active IndicationsDiarrheaAcute PainPain +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeR05DA04
Related LinksWikipediaDrugBankKEGG